BEIJING, May 13 (Reuters) - China's Ministry of PublicSecurity will brief the media on Wednesday about UK drug makerGlaxoSmithKline PLC, which has been under investigationfor allegedly funneling up to 3 billion yuan to travel agenciesto facilitate bribes to doctors and officials.
An official at the ministry declined on Tuesday to commenton the content of the briefing slated for Wednesday at 11am(0300 GMT), only saying it is related to GSK.
Police detained four executives of the British drugmaker inJuly in connection with the bribery allegations.
Legal and industry sources had told Reuters in November thatChinese police were likely to charge some of GSK's Chineseexecutives but not the British drugmaker itself.
The company has said previously that some of its seniorChinese executives appear to have broken the law, and that ithas zero tolerance for bribery. (Reporting by Hui Li and Megha Rajagopalan; Writing by JohnRuwitch; Editing by Muralikumar Anantharaman)
Glaxosmithkline (GSK)